Literature DB >> 11880724

Management of glaucoma after retinal detachment surgery.

Steven J Gedde1.   

Abstract

Secondary glaucoma may complicate retinal detachment surgery. Intraocular pressure (IOP) elevation has been described after scleral buckling procedures and vitrectomy with intravitreal injection of gas or silicone oil. Angle-closure glaucoma after scleral buckling develops because of congestion and anterior rotation of the ciliary body. Medical therapy and laser iridoplasty are usually successful in controlling IOP, but the presence of conjunctival scarring and recession and retinal hardware after scleral buckling procedures can make surgical management challenging. Intravitreal injection of expansile gases like sulfur hexafluoride (SF6) and perfluoropropene (C3F8) may produce secondary angle-closure glaucoma with or without pupillary block. Aspiration of a portion of the intraocular gas may be needed, especially if IOP is elevated to a level that may compromise ocular perfusion. Glaucoma also can develop after intravitreal injection of silicone oil secondary to pupillary block, inflammation, synechial angle closure, rubeosis iridis, or migration of emulsified or nonemulsified silicone oil into the anterior chamber. A prophylactic inferior iridectomy at the time of surgery serves to prevent pupillary block. Patients with medically uncontrolled glaucoma after silicone oil injection may require oil removal with or without concurrent glaucoma surgery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11880724     DOI: 10.1097/00055735-200204000-00009

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  27 in total

1.  [Glaucoma and retinal surgery].

Authors:  M Müller; G Geerling; M Zierhut; T Klink
Journal:  Ophthalmologe       Date:  2010-05       Impact factor: 1.059

Review 2.  [Vitrectomy with or without cerclage in the treatment of retinal detachment].

Authors:  F Ziemssen; K U Bartz-Schmidt
Journal:  Ophthalmologe       Date:  2004-06       Impact factor: 1.059

3.  Vitrectomy does not increase the risk of open-angle glaucoma or ocular hypertension--a 5-year follow-up.

Authors:  Alice L Yu; Wolfgang Brummeisl; Markus Schaumberger; Anselm Kampik; Ulrich Welge-Lussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-20       Impact factor: 3.117

Review 4.  Rhegmatogenous retinal detachment--an ophthalmologic emergency.

Authors:  Nicolas Feltgen; Peter Walter
Journal:  Dtsch Arztebl Int       Date:  2014-01-06       Impact factor: 5.594

5.  Goniosynechialysis for secondary angle closure glaucoma in a pseudophakic patient after vitrectomy and silicone oil injection.

Authors:  Jonghoon Shin; Hyeshin Jeon; Ik Soo Byon; Ji-Woong Lee
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

6.  Vitrectomy with scleral buckling versus with inferior retinectomy in treating primary rhegmatogenous retinal detachment with PVR and inferior breaks.

Authors:  Khaled G Abu Eleinen; Ahmed A Mohalhal; Dalia A Ghalwash; Ahmed A Abdel-Kader; Ahmed A Ghalwash; Islam A Mohalhal; Abdussalam M Abdullatif
Journal:  Eye (Lond)       Date:  2018-12-19       Impact factor: 3.775

Review 7.  Lasers in Glaucoma: an Overview.

Authors:  Bhawesh Chandra Saha; Rashmi Kumari; Bibhuti Prasanna Sinha; Anita Ambasta; Sanjeev Kumar
Journal:  Int Ophthalmol       Date:  2020-11-19       Impact factor: 2.031

8.  Long term outcome of secondary glaucoma following vitreoretinal surgery.

Authors:  P Tranos; R Asaria; W Aylward; P Sullivan; W Franks
Journal:  Br J Ophthalmol       Date:  2004-03       Impact factor: 4.638

9.  Glaucoma associated with the management of rhegmatogenous retinal detachment.

Authors:  George Mangouritsas; Spyridon Mourtzoukos; Dimitra M Portaliou; Vassilios I Georgopoulos; Anastasia Dimopoulou; Elias Feretis
Journal:  Clin Ophthalmol       Date:  2013-04-15

10.  Descemet-stripping automated endothelial keratoplasty for vitrectomized cases with traumatic aniridia and aphakic bullous keratopathy.

Authors:  Hiroshi Eguchi; Tatsuro Miyamoto; Fumika Hotta; Machiko Tomida; Masayuki Inoue; Yoshinori Mitamura
Journal:  Clin Ophthalmol       Date:  2012-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.